CLARIANE SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.35 EUR | -6.45% |
|
+25.00% | -2.25% |
| Apr. 29 | CLARIANE : Expecting a smaller dilution effect |  |
| Apr. 26 | CLARIANE : Reiterated outlook backed by a buoyant Q1 | |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 5.29B 5.7B | Sales 2025 * | 5.58B 6B | Capitalization | 251M 270M |
|---|---|---|---|---|---|
| Net income 2024 * | 15M 16.14M | Net income 2025 * | 58M 62.42M | EV / Sales 2024 * | 1.17 x |
| Net Debt 2024 * | 5.93B 6.38B | Net Debt 2025 * | 4.76B 5.13B | EV / Sales 2025 * | 0.9 x |
| P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
4.9
x | Employees | 56,000 |
| Yield 2024 * |
14.5% | Yield 2025 * |
17.4% | Free-Float | 62.56% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clariane SE
More news
| 1 day | -6.45% | ||
| 1 week | +25.00% | ||
| Current month | +4.44% | ||
| 1 month | +36.23% | ||
| 3 months | +4.44% | ||
| 6 months | -40.05% | ||
| Current year | -2.25% |
1 week
2.14
2.57
1 month
1.562.57
Current year
1.322.68
1 year
1.328.05
3 years
1.3234.76
5 years
1.3245.66
10 years
1.3245.66
| Managers | Title | Age | Since |
|---|---|---|---|
Sophie Boissard
CEO | Chief Executive Officer | 53 | 16-01-25 |
| Director of Finance/CFO | - | 18-03-31 | |
| Chief Tech/Sci/R&D Officer | - | 20-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 47 | 21-01-10 | |
Catherine Soubie
BRD | Director/Board Member | 58 | 14-03-17 |
| Chairman | 72 | 16-06-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 2.35 | -6.45% | 1,087,311 |
| 24-05-02 | 2.512 | +11.64% | 1,354,876 |
| 24-04-30 | 2.25 | +1.35% | 1,609,821 |
| 24-04-29 | 2.22 | +18.09% | 1,844,697 |
Real-time Euronext Paris, May 03, 2024 at 11:35 am EDT
More quotes
Clariane SE (formerly Korian) is the European No. 1 private operator of full-care facilities for dependent people. Net sales break down by geographic zone as follows:
- France (49.1%): at the end of 2022, operated 619 facilities (32,974 beds) broken into assisted-living facilities (medical assisted living facilities for the elderly, retirement homes, long-term care facilities and rest homes) and medical facilities (follow-up care and rehabilitation clinics and psychiatric clinics). In addition, the group operates 55 facilities (3,092 beds) in Spain and 11 facilities (727 beds) in the United Kingdom;
- Germany (23.9%): operated 239 facilities (27,392 beds);
- Belgium (14.7%): operated 117 facilities (12,991 beds). Furthermore, the group operates 49 facilities (1,458 beds) in the Netherlands;
- Italy (12.3%): operated 110 facilities (9,360 beds).
Calendar
2024-06-12
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2.35
EUR
Average target price
3.825
EUR
Spread / Average Target
+62.77%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.25% | 270M | |
| +13.70% | 80.61B | |
| -29.20% | 70.18B | |
| +9.86% | 29.08B | |
| -11.43% | 16.97B | |
| -0.43% | 16.96B | |
| -0.31% | 15.26B | |
| +3.42% | 12.41B | |
| -30.70% | 11.95B | |
| -6.75% | 11.93B |
- Stock Market
- Equities
- CLARI Stock
